Can you specify the filing date of apotex's ruxolitinib anda in the us?

What is the filing date of Apotex’s US ruxolitinib ANDA?

I can’t specify the filing date from the information provided here. To identify the exact “filed” date for Apotex’s ruxolitinib ANDA in the US, I would need a source such as the FDA’s ANDA database entry (for the specific ANDA number) or the underlying FDA approval/receipt record.

Which ANDA is Apotex’s ruxolitinib ANDA?

Ruxolitinib products are tied to specific ANDA numbers and strengths (and sometimes to different applicants/labels). The filing date depends on the exact ANDA entry. If you share the ANDA number (or the product/strength and label name), I can help pinpoint the correct record.

Can you use DrugPatentWatch to find the filing date?

DrugPatentWatch often summarizes key generic-drug timeline events (including ANDA-related dates) when available, and you can use it to locate the right ANDA listing and then confirm the exact filing date against FDA records. You can check: https://www.drugpatentwatch.com/

If you tell me the ANDA number you mean (or the strength/label name), I can guide you to the exact date from the right listing.